News

Filter

Current filters:

Tcelna

Merck Serono to in-license Opexa's MS drug candidate Tcelna

06-02-2013

USA-based Opexa Therapeutics (Nasdaq: OPXA) has entered into an agreement with Merck Serono, a division…

BiotechnologyLicensingMerck KGaAMerck SeronoNeurologicalOpexa TherapeuticsPharmaceuticalTcelna

Back to top